Short Interest in PURE Bioscience, Inc. (OTCMKTS:PURE) Expands By 50.0%

PURE Bioscience, Inc. (OTCMKTS:PURE) saw a large increase in short interest in March. As of March 15th, there was short interest totalling 900 shares, an increase of 50.0% from the February 28th total of 600 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily volume of 106,200 shares, the short-interest ratio is presently 0.0 days.

PURE Bioscience Stock Up 1.2 %

PURE stock traded up $0.00 during midday trading on Tuesday, hitting $0.09. The company’s stock had a trading volume of 7,500 shares, compared to its average volume of 64,240. PURE Bioscience has a 12 month low of $0.05 and a 12 month high of $0.16. The company has a 50 day moving average of $0.07 and a two-hundred day moving average of $0.08. The firm has a market capitalization of $10.42 million, a price-to-earnings ratio of -2.33 and a beta of 0.35.

PURE Bioscience (OTCMKTS:PURE) last issued its earnings results on Monday, March 17th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.39 million for the quarter.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.